Stockscreener 앱 받기
4.52
4.87%
0.21
시간 외 거래:
4.53
0.01
+0.22%
Briacell Therapeutics Corp 주식(BCTX)의 최신 뉴스
Aug Outlook: Is BriaCell Therapeutics Corp Equity Warrant benefiting from innovation trends2026 Sentiment & Smart Allocation Stock Tips - baoquankhu1.vn
BriaCell (BCTX) to Reveal Key Findings at 2026 AACR Annual Meeti - GuruFocus
BriaCell to Spotlight Phase 3 Bria-IMT Data and Next-Gen Bria-OTS+ Platform at 2026 AACR - TipRanks
BriaCell to Present Positive Clinical Data for Bria-IMT and Preclinical Data for Next Generation Bria-OTS+ Personalized Immunotherapy at the 2026 AACR Conference - Bitget
BriaCell to Present Positive Clinical Data for Bria-IMT™ - GlobeNewswire
(BCT) Strategic Investment Guide (BCT:CA) - Stock Traders Daily
Published on: 2026-03-12 08:04:05 - baoquankhu1.vn
Take Profit: Is BriaCell Therapeutics Corp Equity Warrant benefiting from innovation trends2026 Buyback Activity & Daily Entry Point Trade Alerts - baoquankhu1.vn
BriaCell Therapeutics Corp. 2026 Q2 Financial Results and Nasdaq Listing Overview - Minichart
Why did BCTX stock surge 50% today? - MSN
BriaCell (NASDAQ: BCTX) boosts cash to fund cancer trials amid higher losses - Stock Titan
BriaCell Therapeutics Corp. Files Form 8-K: Company Details, NASDAQ Ticker Symbols, and Key Disclosures (March 2026) 343637 - Minichart
BriaCell to Present Four Poster Presentations at the 2026 AACR Annual Meeting - Yahoo Finance
BriaCell Shareholders Approve Auditors and Reelect Board - TipRanks
BriaCell (NASDAQ: BCTX) shareholders re-approve equity plan and board slate - Stock Titan
Why retail investors favor BriaCell Therapeutics Corp. stock2026 Earnings Impact & Real-Time Chart Pattern Alerts - Naître et grandir
IPO Launch: How does BriaCell Therapeutics Corp Equity Warrant compare to its peersWeekly Stock Analysis & High Accuracy Trade Signal Alerts - baoquankhu1.vn
What sentiment indicators say about BriaCell Therapeutics Corp. Equity Warrant stock2025 Price Action Summary & Free High Return Stock Watch Alerts - Naître et grandir
Market Pulse: What is the next catalyst for BriaCell Therapeutics Corp2025 Bull vs Bear & Precise Buy Zone Identification - baoquankhu1.vn
Why is BriaCell Therapeutics Corp stock going downQuarterly Growth Report & Short-Term High Return Ideas - baoquankhu1.vn
Merger Talk: How does BriaCell Therapeutics Corp Equity Warrant compare to its peersWeekly Volume Report & Weekly Momentum Stock Picks - baoquankhu1.vn
How To Trade (BCT) (BCT:CA) - Stock Traders Daily
Retail Trends: Does BriaCell Therapeutics Corp align with a passive investing strategy2025 Market Sentiment & Growth-Oriented Investment Plans - baoquankhu1.vn
BCT.CA Earnings History & Surprises | EPS & Revenue Results | BRIACELL THERAPEUTICS CORP (TSX:BCT) - ChartMill
BriaCell Therapeutics Corp. Announces Results of Shareholder Meeting - Investing News Network
BriaCell Shareholders Overwhelmingly Back Board and Auditors at Annual Meeting - TipRanks
Aug Retail: Can BriaCell Therapeutics Corp ride the EV waveEntry Point & Smart Money Movement Alerts - baoquankhu1.vn
AI Stocks: Is Putnam Master Intermediate Income Trust stock risky to hold nowMarket Sentiment Report & Real-Time Market Trend Scan - baoquankhu1.vn
BriaCell Therapeutics: Key Catalysts on the Horizon for Investors - AD HOC NEWS
Trading (BCT) With Integrated Risk Controls (BCT:CA) - Stock Traders Daily
EPS Watch: Is BriaCell Therapeutics Corp a defensive stockEarnings Risk Summary & Smart Investment Allocation Tips - baoquankhu1.vn
BCTXZBriacell Therapeutics Corp Latest Stock News & Market Updates - Stock Titan
(BCT) Equity Trading Insights (BCT:CA) - Stock Traders Daily
BCTXBriacell Therapeutics Corp Latest Stock News & Market Updates - Stock Titan
Basic earnings per share (basic EPS) of BriaCell Therapeutics Corp. – NASDAQ:BCTXZ - TradingView
Price to earnings ratio of BriaCell Therapeutics Corp. – NASDAQ:BCTXZ - TradingView
Number of employees of BriaCell Therapeutics Corp. – NASDAQ:BCTXZ - TradingView
BCTXL | BriaCell Therapeutics Corp. Warrant Institutional Ownership - Quiver Quantitative
BCTX Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
BCTXW SEC FilingsBriacell Therapeutics Corp 10-K, 10-Q, 8-K Forms - Stock Titan
Net income of BriaCell Therapeutics Corp. – NASDAQ:BCTXZ - TradingView
BriaCell Therapeutics (BCTX) files Form 25 to remove Warrants from Nasdaq - Stock Titan
BCTXW Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
Street Watch: Is BriaCell Therapeutics Corp a defensive stock2025 Performance Recap & Capital Efficiency Focused Ideas - baoquankhu1.vn
BriaCell and BriaPro Enter Into Asset Purchase Agreement for Exclusive Soluble CD80 License - National Today
BCTXZ Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
BriaCell spins off sCD80 cancer therapy to BriaPro in strategic deal - Indian Pharma Post
BriaCell Restructures Soluble CD80 Program via BriaPro Deal - TipRanks
BriaCell enters asset sale to BriaPro for sCD80, receives 23.97M shares and up to $3M credit - TradingView
(BCT) Investment Performance Report (BCT:CA)Stock Traders Daily Canada - Stock Traders Daily
Is BriaCell Therapeutics Corp. stock a top pick in earnings seasonJuly 2025 Catalysts & Risk Adjusted Buy and Sell Alerts - mfd.ru
Bull Run: What is BriaCell Therapeutics Corp. Equity Warrant’s valuation compared to sector2025 Geopolitical Influence & Weekly Setup with High ROI Potential - mfd.ru
BriaCell Adds UCLA Health as Key Site in Pivotal Phase 3 Breast Cancer Study - Intellectia AI
BriaCell (BCTX) Expands Biologic Cancer Treatments Through New A - GuruFocus
BriaPro to Acquire BriaCell’s Soluble CD80 License in Strategic Cancer Immunotherapy Deal - TipRanks
Briacell, Briapro enter into asset purchase agreement for exclusive soluble CD80 license - marketscreener.com
BriaCell Therapeutics Brief: BriaCell and BriaPro Entering Into Asset Purchase Agreement for Exclusive Soluble CD80 License - marketscreener.com
Will BriaCell Therapeutics Corp. Equity Warrant stock maintain momentum in 2025Market Activity Report & Verified Chart Pattern Signals - mfd.ru
BriaCell Therapeutics Corp. Receives Positive Recommendation from Data Safety Monitoring Board for Phase 3 Study in Metastatic Breast Cancer - marketscreener.com
(BCT) Technical Patterns and Signals (BCT:CA) - Stock Traders Daily
BriaCell Wins Fifth Straight Safety Nod for Fast-Track Phase 3 Breast Cancer Trial - TipRanks
BriaCell Therapeutics' Phase 3 Breast Cancer Treatment Trial Gets Fifth DSMB Recommendation to Continue - marketscreener.com
Data Safety Review Board Issues Positive Safety Recommendation For BriaCell's Phase 3 Study - marketscreener.com
BriaCell Receives Positive Recommendation from Data Safety Monitoring Board (DSMB) for Phase 3 Study in Metastatic Breast Cancer - The Manila Times
BriaCell Receives Positive Recommendation from Data Safety - GlobeNewswire
1.20%
0.06%
자본화:
|
볼륨(24시간):